HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiyuki Suehara Selected Research

Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)

11/2020Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
3/2015Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiyuki Suehara Research Topics

Disease

43Neoplasms (Cancer)
01/2022 - 01/2004
11Sarcoma (Soft Tissue Sarcoma)
04/2021 - 08/2006
10Neoplasm Metastasis (Metastasis)
03/2021 - 05/2011
9Adenocarcinoma of Lung
03/2022 - 12/2012
9Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2018 - 03/2008
5Osteosarcoma (Osteogenic Sarcoma)
11/2019 - 09/2008
4Lung Neoplasms (Lung Cancer)
03/2022 - 09/2014
4Leiomyosarcoma
04/2021 - 08/2006
4Microsatellite Instability
01/2021 - 01/2017
4Giant Cell Tumors (Giant Cell Tumor)
01/2019 - 10/2011
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021 - 11/2019
2Desmoplastic Small Round Cell Tumor
01/2022 - 04/2004
2Ewing Sarcoma (Sarcoma, Ewing)
10/2021 - 03/2018
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
07/2021 - 06/2021
2Neurofibrosarcoma (MPNST)
04/2021 - 09/2008
2Carcinogenesis
01/2021 - 11/2016
2Melanoma (Melanoma, Malignant)
01/2021 - 10/2016
2Adenocarcinoma
09/2020 - 01/2018
2Alveolar Soft Part Sarcoma
01/2017 - 10/2016
2Desmoplastic Fibroma
05/2014 - 01/2013
2Synovial Sarcoma (Synovioma)
05/2011 - 09/2008
1Lymphatic Metastasis
01/2021
1Pulmonary Fibrosis (Fibrosing Alveolitis)
07/2020
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2020
1Giant Cell Tumor of Bone
01/2020
1Stomach Neoplasms (Stomach Cancer)
01/2018
1Turcot syndrome
01/2017
1Autoimmune Diseases (Autoimmune Disease)
10/2016
1Rheumatoid Arthritis
10/2016
1Ulcer
07/2016

Drug/Important Bio-Agent (IBA)

20Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2006
15Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2006
7Phosphotransferases (Kinase)IBA
10/2021 - 05/2014
7Tyrosine Kinase InhibitorsIBA
10/2021 - 09/2014
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 05/2014
4DenosumabFDA Link
01/2020 - 12/2014
4Formaldehyde (Formol)FDA Link
12/2019 - 06/2013
4ParaffinIBA
12/2019 - 06/2013
3RNA (Ribonucleic Acid)IBA
10/2021 - 05/2014
3Protein Isoforms (Isoforms)IBA
07/2021 - 08/2006
3Messenger RNA (mRNA)IBA
04/2021 - 12/2012
3Tyrosine (L-Tyrosine)FDA Link
04/2021 - 03/2015
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2021 - 12/2012
3Immune Checkpoint InhibitorsIBA
03/2021 - 10/2016
3Gefitinib (Iressa)FDA Link
11/2019 - 01/2015
3TropomyosinIBA
10/2019 - 08/2006
3Telomerase (Telomerase Reverse Transcriptase)IBA
01/2016 - 01/2015
3CollagenIBA
01/2015 - 01/2013
2larotrectinibIBA
11/2021 - 10/2019
2Thyroid Nuclear Factor 1IBA
07/2021 - 06/2021
2Pharmaceutical PreparationsIBA
04/2021 - 10/2016
2MucinsIBA
03/2021 - 01/2021
2tyrosine receptor (receptor, tyrosine)IBA
11/2020 - 05/2014
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
11/2020 - 03/2015
2GlypicansIBA
09/2020 - 01/2018
2Transcription Factor 4IBA
11/2019 - 01/2018
2cabozantinibIBA
01/2017 - 06/2013
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2016 - 05/2014
2Monoclonal AntibodiesIBA
06/2013 - 01/2010
1Transcription Factors (Transcription Factor)IBA
03/2022
1AfatinibIBA
01/2022
1Cetuximab (Erbitux)FDA Link
01/2022
1B7-H1 AntigenIBA
11/2021
1entrectinibIBA
11/2021
1Carcinoembryonic AntigenIBA
11/2021
1Cell-Free Nucleic AcidsIBA
10/2021
1Indicators and Reagents (Reagents)IBA
04/2021
1Immunoglobulins (Immunoglobulin)IBA
03/2021
1phosphatidyl-N-monomethylaminoethanolIBA
01/2021
1pazopanibFDA Link
11/2020
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
11/2020
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2020
1nintedanibIBA
07/2020
1Transforming Growth Factors (Transforming Growth Factor)IBA
07/2020
1osimertinibIBA
01/2020
1Insulin (Novolin)FDA Link
01/2020
1NucleotidesIBA
04/2019
1pembrolizumabIBA
02/2019
1Fetal Proteins (Fetoprotein)IBA
01/2018
1GlycogenIBA
01/2018
1Mucin-1 (CA 15-3 Antigen)IBA
01/2018
1Trastuzumab (Herceptin)FDA Link
01/2018
1PENTAIBA
01/2017
1PromegaIBA
01/2017
1Dasatinib (BMS 354825)FDA Link
01/2017
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
11/2016
1Arginine (L-Arginine)FDA Link
10/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2016
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2016
1Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA
10/2016
1AntibodiesIBA
10/2016
1NivolumabIBA
10/2016
1Bevacizumab (Avastin)FDA Link
07/2016

Therapy/Procedure

19Therapeutics
10/2021 - 08/2006
7Drug Therapy (Chemotherapy)
10/2021 - 04/2004
3Immunotherapy
01/2022 - 03/2021
3Precision Medicine
06/2021 - 04/2019
3Curettage
01/2020 - 10/2011
2Radiotherapy
01/2021 - 11/2020
1Transplantation
01/2021